McSharry Heather Ann's Form 4 filing
Jazz Pharmaceuticals plcJAZZ · filed Nov 24, 2025
- Accession no.
- 0001576068-25-000005
- Filed
- Nov 24, 2025
- Trade date
- Nov 20, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $607.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McSharry Heather AnnCIK 0001576068 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | Ordinary Shares | MOption exerciseAcquired | +3,415 | $138.08 | +$471,543.2 | 23,864 | Direct | |
| Nov 20, 2025 | Ordinary Shares | SSaleDisposed | −3,415 | $177.78 | −$607,118.7 | 20,449 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | Ordinary Shares | MOption exerciseDisposed | −3,415 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.